Figure 4From: Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models Quantitation of Aβ burden in the hippocampus of TgSwDI mice. Representative brain sections of both (A) vehicle control and (B) pBri-treated Tg mice immunostained with anti-Aβ antibodies 4G8 and 6E10 from the hippocampus. (C) Bar graph of amyloid burden calculated using stereology for the hippocampus of vehicle control and pBri-vaccinated TgSwDI mice. On average there was a 42% reduction in the areas occupied by 4G8/6E10 immunoreactivity (*P = 0.039 by an unpaired two-tailed t-test). Tg, transgenic.Back to article page